Skip to content

AmerisourceBergen board to face investor lawsuit over cancer unit malfeasance

August 24, 2020

A Delaware court has ruled against a motion by the board of directors of drug wholesaler AmerisourceBergen (NYSE:ABC) to dismiss an investor lawsuit regarding alleged illegal behavior by its Oncology Supply Pharmacy Services unit that used overfill quantities of cancer medicines to fill up additional syringes in an unsterile process leading to contaminated drugs.

The plaintiffs claim that the board allowed the subsidiary to be run like a “criminal organization” by ignoring red flags and permitting a “woefully inadequate” reporting system.

ABC representatives have yet to comment on the litigation.

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: